M. A. Cikrikcioglu Et Al. , "Association of calcium channel blocker use with lower hemoglobin levels in chronic kidney disease," EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES , vol.17, no.18, pp.2530-2537, 2013
Cikrikcioglu, M. A. Et Al. 2013. Association of calcium channel blocker use with lower hemoglobin levels in chronic kidney disease. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES , vol.17, no.18 , 2530-2537.
Cikrikcioglu, M. A., Karatoprak, C., Cakirca, M., Kiskac, M., Zorlu, M., Cetin, G., ... Yildiz, K.(2013). Association of calcium channel blocker use with lower hemoglobin levels in chronic kidney disease. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES , vol.17, no.18, 2530-2537.
Cikrikcioglu, M. Et Al. "Association of calcium channel blocker use with lower hemoglobin levels in chronic kidney disease," EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES , vol.17, no.18, 2530-2537, 2013
Cikrikcioglu, M. A. Et Al. "Association of calcium channel blocker use with lower hemoglobin levels in chronic kidney disease." EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES , vol.17, no.18, pp.2530-2537, 2013
Cikrikcioglu, M. A. Et Al. (2013) . "Association of calcium channel blocker use with lower hemoglobin levels in chronic kidney disease." EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES , vol.17, no.18, pp.2530-2537.
@article{article, author={M. A. Cikrikcioglu Et Al. }, title={Association of calcium channel blocker use with lower hemoglobin levels in chronic kidney disease}, journal={EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES}, year=2013, pages={2530-2537} }